NYSE:GMED - New York Stock Exchange, Inc. - US3795772082 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 78% to GMED. The Buy consensus is the weighted average rating of the current analysts ratings.
Date | Firm | Action | Rating |
---|---|---|---|
2025-01-10 | Canaccord Genuity | Maintains | Buy -> Buy |
2025-01-09 | Needham | Reiterate | Hold -> Hold |
2025-01-09 | B of A Securities | Upgrade | Underperform -> Neutral |
2024-12-18 | Truist Securities | Maintains | Hold -> Hold |
2024-12-17 | Roth MKM | Maintains | Buy -> Buy |
2024-12-12 | BTIG | Maintains | Buy -> Buy |
2024-12-11 | Wells Fargo | Maintains | Overweight -> Overweight |
2024-12-09 | Canaccord Genuity | Maintains | Buy -> Buy |
2024-12-02 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
2024-11-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
2024-11-07 | Needham | Reiterate | Hold |
2024-11-06 | Roth MKM | Reiterate | Buy -> Buy |
2024-11-06 | Needham | Reiterate | Hold |
2024-11-06 | RBC Capital | Maintains | Outperform -> Outperform |
2024-11-06 | Stifel | Maintains | Buy -> Buy |
2024-11-06 | Wells Fargo | Maintains | Overweight -> Overweight |
2024-11-06 | Canaccord Genuity | Maintains | Buy -> Buy |
2024-11-06 | B of A Securities | Maintains | Underperform -> Underperform |
2024-11-06 | Piper Sandler | Maintains | Overweight -> Overweight |
2024-10-14 | BTIG | Maintains | Buy -> Buy |
2024-10-08 | RBC Capital | Maintains | Outperform -> Outperform |
2024-08-28 | BTIG | Maintains | Buy -> Buy |
2024-08-08 | Barclays | Maintains | Overweight -> Overweight |
2024-08-07 | Needham | Reiterate | Hold |
2024-08-07 | RBC Capital | Maintains | Outperform -> Outperform |
2024-08-07 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
2024-08-07 | Truist Securities | Maintains | Hold -> Hold |
2024-07-16 | Truist Securities | Maintains | Hold -> Hold |
2024-07-15 | BTIG | Maintains | Buy -> Buy |
2024-07-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |